世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031619

掻痒症治療薬の世界市場(2022-2026)

TechNavio

Global Pruritus Drugs Market 2022-2026

発刊日 2022/03/02

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000031619

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、世界の掻痒症治療薬市場を分析します。

世界の掻痒症治療薬市場は、予測期間中に約8.06 %のCAGRで推移し、2022年から2026年の間に68億7,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、免疫療法への嗜好の高まり、慢性疾患の有病率の上昇、および治療法の認識と使用の増加によって推進されています。 さらに、免疫療法に対する嗜好の高まりは、市場の成長も後押しすると予想されます。

調査範囲

  • 市場セグメント
    ➣ アプリケーション別
      ◇ 血液性掻痒症
      ◇ 腫瘍性掻痒症
      ◇ 腎掻痒症
      ◇ 内分泌掻痒症
      ◇ 胆汁うっ滞性掻痒
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、新しい治療法の出現が、今後数年間の掻痒症治療薬市場の成長を促進する主要な理由の1つであると位置づけています。また、ナノ粒子対応の経皮ドラッグデリバリーシステムと研究資金の増加が、市場の大きな需要につながるでしょう。

Technavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 掻痒症治療薬の市場規模
  • 掻痒症治療薬の市場予測
  • 掻痒症治療薬市場の業界分析

Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な掻痒症治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Almirall SA
    ➣ Astellas Pharma Inc.
    ➣ Bristol-Myers Squibb Co.
    ➣ Cara Therapeutics Inc.
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ Glenmark Pharmaceuticals Ltd.
    ➣ Ipca Laboratories Ltd.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Roivant Sciences Ltd.
    ➣ Sanofi SA
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Cipla Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Lupin Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application
5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Hematologic pruritus - Market size and forecast 2021-2026
Exhibit 28: Chart on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 30: Chart on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
5.4 Oncological pruritus - Market size and forecast 2021-2026
Exhibit 32: Chart on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 33: Data Table on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 34: Chart on Oncological pruritus - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Oncological pruritus - Year-over-year growth 2021-2026 (%)
5.5 Renal pruritus - Market size and forecast 2021-2026
Exhibit 36: Chart on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 37: Data Table on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 38: Chart on Renal pruritus - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Renal pruritus - Year-over-year growth 2021-2026 (%)
5.6 Endocrine pruritus - Market size and forecast 2021-2026
Exhibit 40: Chart on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 41: Data Table on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 42: Chart on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
5.7 Cholestatic pruritus - Market size and forecast 2021-2026
Exhibit 44: Chart on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 45: Data Table on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibit 46: Chart on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
5.8 Market opportunity by Application
Exhibit 48: Market opportunity by Application ($ billion)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 86: Chart on France - Market size and forecast 2021-2026 ($ billion)
Exhibit 87: Data Table on France - Market size and forecast 2021-2026 ($ billion)
Exhibit 88: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 90: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 97: AbbVie Inc. - Overview
Exhibit 98: AbbVie Inc. - Business segments
Exhibit 99: AbbVie Inc. - Key offerings
Exhibit 100: AbbVie Inc. - Segment focus
10.4 Astellas Pharma Inc.
Exhibit 101: Astellas Pharma Inc. - Overview
Exhibit 102: Astellas Pharma Inc. - Product / Service
Exhibit 103: Astellas Pharma Inc. - Key news
Exhibit 104: Astellas Pharma Inc. - Key offerings
10.5 Cara Therapeutics Inc.
Exhibit 105: Cara Therapeutics Inc. - Overview
Exhibit 106: Cara Therapeutics Inc. - Product / Service
Exhibit 107: Cara Therapeutics Inc. - Key offerings
10.6 GlaxoSmithKline Plc
Exhibit 108: GlaxoSmithKline Plc - Overview
Exhibit 109: GlaxoSmithKline Plc - Business segments
Exhibit 110: GlaxoSmithKline Plc - Key news
Exhibit 111: GlaxoSmithKline Plc - Key offerings
Exhibit 112: GlaxoSmithKline Plc - Segment focus
10.7 Lupin Ltd.
Exhibit 113: Lupin Ltd. - Overview
Exhibit 114: Lupin Ltd. - Product / Service
Exhibit 115: Lupin Ltd. - Key news
Exhibit 116: Lupin Ltd. - Key offerings
10.8 Merck and Co. Inc.
Exhibit 117: Merck and Co. Inc. - Overview
Exhibit 118: Merck and Co. Inc. - Business segments
Exhibit 119: Merck and Co. Inc. - Key news
Exhibit 120: Merck and Co. Inc. - Key offerings
Exhibit 121: Merck and Co. Inc. - Segment focus
10.9 Novartis AG
Exhibit 122: Novartis AG - Overview
Exhibit 123: Novartis AG - Business segments
Exhibit 124: Novartis AG - Key offerings
Exhibit 125: Novartis AG - Segment focus
10.10 Pfizer Inc.
Exhibit 126: Pfizer Inc. - Overview
Exhibit 127: Pfizer Inc. - Business segments
Exhibit 128: Pfizer Inc. - Key news
Exhibit 129: Pfizer Inc. - Key offerings
Exhibit 130: Pfizer Inc. - Segment focus
10.11 Roivant Sciences Ltd.
Exhibit 131: Roivant Sciences Ltd. - Overview
Exhibit 132: Roivant Sciences Ltd. - Product / Service
Exhibit 133: Roivant Sciences Ltd. - Key offerings
10.12 Sanofi SA
Exhibit 134: Sanofi SA - Overview
Exhibit 135: Sanofi SA - Business segments
Exhibit 136: Sanofi SA - Key news
Exhibit 137: Sanofi SA - Key offerings
Exhibit 138: Sanofi SA - Segment focus

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 139: Inclusions checklist
Exhibit 140: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 141: Currency conversion rates for US$
11.4 Research methodology
Exhibit 142: Research methodology
Exhibit 143: Validation techniques employed for market sizing
Exhibit 144: Information sources
11.5 List of abbreviations
Exhibit 145: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on Oncological pruritus - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oncological pruritus - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Renal pruritus - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Renal pruritus - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Application ($ billion)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on France - Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on France - Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: AbbVie Inc. - Overview
Exhibits98: AbbVie Inc. - Business segments
Exhibits99: AbbVie Inc. - Key offerings
Exhibits100: AbbVie Inc. - Segment focus
Exhibits101: Astellas Pharma Inc. - Overview
Exhibits102: Astellas Pharma Inc. - Product / Service
Exhibits103: Astellas Pharma Inc. - Key news
Exhibits104: Astellas Pharma Inc. - Key offerings
Exhibits105: Cara Therapeutics Inc. - Overview
Exhibits106: Cara Therapeutics Inc. - Product / Service
Exhibits107: Cara Therapeutics Inc. - Key offerings
Exhibits108: GlaxoSmithKline Plc - Overview
Exhibits109: GlaxoSmithKline Plc - Business segments
Exhibits110: GlaxoSmithKline Plc - Key news
Exhibits111: GlaxoSmithKline Plc - Key offerings
Exhibits112: GlaxoSmithKline Plc - Segment focus
Exhibits113: Lupin Ltd. - Overview
Exhibits114: Lupin Ltd. - Product / Service
Exhibits115: Lupin Ltd. - Key news
Exhibits116: Lupin Ltd. - Key offerings
Exhibits117: Merck and Co. Inc. - Overview
Exhibits118: Merck and Co. Inc. - Business segments
Exhibits119: Merck and Co. Inc. - Key news
Exhibits120: Merck and Co. Inc. - Key offerings
Exhibits121: Merck and Co. Inc. - Segment focus
Exhibits122: Novartis AG - Overview
Exhibits123: Novartis AG - Business segments
Exhibits124: Novartis AG - Key offerings
Exhibits125: Novartis AG - Segment focus
Exhibits126: Pfizer Inc. - Overview
Exhibits127: Pfizer Inc. - Business segments
Exhibits128: Pfizer Inc. - Key news
Exhibits129: Pfizer Inc. - Key offerings
Exhibits130: Pfizer Inc. - Segment focus
Exhibits131: Roivant Sciences Ltd. - Overview
Exhibits132: Roivant Sciences Ltd. - Product / Service
Exhibits133: Roivant Sciences Ltd. - Key offerings
Exhibits134: Sanofi SA - Overview
Exhibits135: Sanofi SA - Business segments
Exhibits136: Sanofi SA - Key news
Exhibits137: Sanofi SA - Key offerings
Exhibits138: Sanofi SA - Segment focus
Exhibits139: Inclusions checklist
Exhibits140: Exclusions checklist
Exhibits141: Currency conversion rates for US$
Exhibits142: Research methodology
Exhibits143: Validation techniques employed for market sizing
Exhibits144: Information sources
Exhibits145: List of abbreviations

この商品のレポートナンバー

0000031619

TOP